By vgreene, 26 March, 2020 Remdesivir 200 mg IV on day 1, then 100 mg IV q24h x9 days vs remdesivir 200 mg IV on day 1, then 100 mg IV x 4 days
By vgreene, 26 March, 2020 Active: Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19)
By vgreene, 26 March, 2020 Location: Various sites in US and Hong Kong, South Korea, Singapore, Taiwan
By vgreene, 26 March, 2020 Remdesivir 200 mg IV on day 1, then 100 mg IV q24h x9 days vs remdesivir 200 mg IV on day 1, then 100 mg IV x 4 days